{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-026223","form_type":"8-K","ticker":"APVO","cik":"0001671584","company_name":"Aptevo Therapeutics Inc.","filed_at":"2024-03-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.053760+00:00","generated_at":"2026-06-05T03:50:26.063468+00:00","sec_items":["5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Aptevo Therapeutics completes 1-for-44 reverse stock split effective March 5, 2024","bullets":["Stockholders approved reverse split at Special Meeting on February 5, 2024; board set ratio on February 27.","Certificate of Amendment filed with Delaware on March 4; effective at 5:01 p.m. ET on March 5.","Every 44 outstanding shares combined into 1 share; no fractional shares issued.","Split-adjusted trading on Nasdaq begins March 6; new CUSIP number 03835L 306.","Proportionate adjustments made to stock options, RSUs, warrants, and equity plan reserves."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-026223","json":"https://secwatch.observer/filing/0000950170-24-026223.json","markdown":"https://secwatch.observer/filing/0000950170-24-026223.md","text":"https://secwatch.observer/filing/0000950170-24-026223.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024026223/0000950170-24-026223-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024026223/apvo-20240305.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T03:50:26.063468+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ba72d9af84de0cb5c4d95dfb5201027110debf2f","claim":"Aptevo Therapeutics Inc.: Amended certificate of incorporation to effect a 1-for-44 reverse stock split (effective 2024-03-05).","evidence_excerpt":"On March 4, 2024, the Company filed a Certificate of Amendment of Amended and Restated Certificate of Incorporation (the “Amendment”) with the Secretary of State of the State of Delaware to effect a 1-for-44 reverse stock split of the Company’s outstanding common stock. The Amendment was effective at 5:01 p.m. Eastern Time on March 5, 2024 (the “Effective Time”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024026223/0000950170-24-026223-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2024-03-05"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}